James M Lenhard - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

James M Lenhard

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Bioorganic & Medicinal Chemistry Letters|September 20, 2005

2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IVCurt D Haffner, Darryl L McDougald, Steven M Reister, et al.

Journal of Medicinal Chemistry|April 2, 2004

Structure-based design of potent retinoid X receptor alpha agonistsCurt D Haffner, James M Lenhard, Aaron B Miller, et al.

Journal of Medicinal Chemistry|January 12, 2011

Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agentsRaymond J Patch, Lily L Searle, Alexander J Kim, et al.

Biochemistry|May 23, 2002

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology|July 10, 2010

Diabetogenic effect of a series of tricyclic delta opioid agonists structurally related to cyproheptadineEllen E Codd, Judith Baker, Michael R Brandt, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Bioorganic & Medicinal Chemistry Letters|September 20, 2005

2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IVCurt D Haffner, Darryl L McDougald, Steven M Reister, et al.

Journal of Medicinal Chemistry|April 2, 2004

Structure-based design of potent retinoid X receptor alpha agonistsCurt D Haffner, James M Lenhard, Aaron B Miller, et al.

Journal of Medicinal Chemistry|January 12, 2011

Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agentsRaymond J Patch, Lily L Searle, Alexander J Kim, et al.

Biochemistry|May 23, 2002

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology|July 10, 2010

Diabetogenic effect of a series of tricyclic delta opioid agonists structurally related to cyproheptadineEllen E Codd, Judith Baker, Michael R Brandt, et al.

Pageof 2